Physician profile
Mark Purvis
NPI 1326007725
$11,426.85
in general payments reported to CMS, 2019-2025
36 companies · $1,896 in 2025
The $1,896 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $284 · 2021: $536 · 2022: $2,339 · 2023: $5,524 · 2024: $646 · 2025: $1,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,312 · Food and Beverage: $1,446 · Travel and Lodging: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,311.95 |
| Food and Beverage | $1,446.31 |
| Travel and Lodging | $1,307.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,860.23 | 2022-2025 | Davinci Xi, Da Vinci Sp, Da Vinci Surgical System |
| Astellas Pharma US INC | $325.13 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $316.41 | 2019-2025 | |
| Pfizer INC. | $240.05 | 2019-2025 | |
| Aspira Women'S Health INC | $164.47 | 2021-2023 | Ova1 |
| Exeltis, USA INC. | $156.63 | 2020-2025 | Slynd |
| Daiichi Sankyo INC. | $152.63 | 2019-2020 | |
| Sanara Medtech INC. | $101.29 | 2020 | |
| Channel Medsystems, INC. | $94.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.24 | 2021-2025 | |
| Shield Therapeutics INC | $83.51 | 2023-2025 | Accrufer |
| Evofem Biosciences, INC. | $83.34 | 2021 | |
| Organon LLC | $83.24 | 2022-2025 | Nexplanon |
| Sage Therapeutics, LLC | $68.41 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $47.57 | 2024-2025 | Myosure Tissue Removal Device, Aptima, Fluent Fluid Management System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $44.15 | 2024-2025 | |
| Conmed Corporation | $42.48 | 2019-2023 | Airseal |
| Sumitomo Pharma America, INC. | $41.85 | 2024-2025 | Gemtesa |
| Coopersurgical, INC. | $39.93 | 2023-2025 | Paragard T 380a, Wallach Cryosurgical Equipment |
| Mayne Pharma Commercial LLC | $39.03 | 2022 | |
| Axonics, INC. | $38.38 | 2024 | Axonics |
| Exact Sciences Corporation | $37.63 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Agile Therapeutics, INC. | $34.28 | 2021-2024 | Twirla |
| Mylan Pharmaceuticals INC. | $28.85 | 2022 | |
| Convatec INC. | $27.22 | 2024 | |
| Myovant Sciences INC. | $24.45 | 2021 | |
| Lupin INC. | $23.90 | 2019-2020 | |
| Scynexis, INC. | $18.54 | 2022 | |
| Meditrina | $18.23 | 2023-2025 | |
| Boston Scientific Corporation | $16.85 | 2019 | |
| Medline Industries Lp | $15.65 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $14.87 | 2025 | |
| Supernus Pharmaceuticals, INC. | $13.82 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $13.60 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.46 | 2019 | |
| Therapeuticsmd, INC. | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Purvis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.